Page last updated: 2024-10-25

amphetamine and Morbid Obesity

amphetamine has been researched along with Morbid Obesity in 1 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caria, S1
Murtas, S1
Loria, G1
Dioguardi, FS1
Secci, R1
Bolasco, P1

Other Studies

1 other study available for amphetamine and Morbid Obesity

ArticleYear
Morbid obesity in a young woman affected by advanced chronic kidney disease: an exceptional case report. Does a high dose of essential amino acids play a key role in therapeutic success?
    Nutrition & diabetes, 2016, Feb-29, Volume: 6

    Topics: Adult; Amino Acids, Essential; Amphetamine; Anemia; Body Mass Index; C-Reactive Protein; Diet, Prote

2016